Overview and current management of sickle cell disease in Tanzania

GeraldLumanya2 89 views 53 slides Jul 08, 2024
Slide 1
Slide 1 of 53
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30
Slide 31
31
Slide 32
32
Slide 33
33
Slide 34
34
Slide 35
35
Slide 36
36
Slide 37
37
Slide 38
38
Slide 39
39
Slide 40
40
Slide 41
41
Slide 42
42
Slide 43
43
Slide 44
44
Slide 45
45
Slide 46
46
Slide 47
47
Slide 48
48
Slide 49
49
Slide 50
50
Slide 51
51
Slide 52
52
Slide 53
53

About This Presentation

Overview and current management of sickle cell disease in Tanzania


Slide Content

SICKLE CELL DISEASE
Dr. Gerald Lumanya

SICKLE-CELL DISEASE (SCD)
Definition
Sickle-celldisease(SCD) isa
geneticblooddisorder
characterizedbyredbloodcells
thatassumeanabnormal, rigid,
sickleshape.

Sicklingdecreasesthecells' flexibility
duringcirculationandresultsina riskof
variouscomplications.
The sicklingoccursbecauseofa
mutationinthehaemoglobin genewhich
resultsinsubstitutionofglutamicacidby
valineatposition6 oftheβ-chain.

Etiology
Sickle cell anaemia is a hereditary disease
inherited as an autosomal recessive trait.
If both parents are both carriers or sickle
cell trait (i.e. both are sickle cell trait),
the chances are that:
1)25% of the children will have sickle
cell anemia
2)50% of the children will be carriers
3)25% will be normal

Classification of sickle disease
1.Sickle cell anemia (“HbSS", "SS
disease", or "haemoglobin S" )
2.Sickle cell trait (“HbAS" or "sickle cell
trait“).
3.Sickle-haemoglobin C disease (HbSC),
and
4.Sickle beta-plus-thalassaemia (HbS/β+)
and sickle beta-zero-thalassaemia
(HbS/β0)

A WITH BOTH FRONTAL AND BIPARIETAL BOSSING

AN INFANT WITH DACTYLITIS DUE SICKLE CELL ANEMIA

INVESTIGATIONS

Other ancillary laboratory investigations
useful in detection and monitoring of the
disease

PERIPHERAL BLOOD SMEAR SHOWING SICKLED RBC

Only people with Hb AS are resistant
to malaria, since the infestation of
the malaria plasmodium is halted by
the sickling of the cells which it
infests.
Patients with HB SS are not. For
them malaria is the commonest
cause of sickle cell crisis.

Signs and symptoms
Sickle-cell disease may lead to
various acute and chronic
complications, several of which are
potentially lethal.

IMMEDIATELY START EMERGENCY
ASSESSMENT AND TREATMENT

PAIN RELIEF

General Pain relief

Morphine for severe relief of Pain

Treatment of Morphine overdose

FLUID BOLUS(HYDRATION)

BLOOD TRANSFUSION
WITHIN 30-60 MINS

SECONDARY SURVEY

BLOOD CULTURE AND IV ANTIBIOTICS
IMAGING AND RADIOLOGICAL INVESTIGATIONS

DOCUMENTATION AND REASSEMENT
CONSULTATION AND DISPOSITION

MANAGEMENT OF ACUTE
COMPLICATIONS OF SCD
Full systematic examination should be
done to all patients
FBP should be taken to all patients
presenting with acute complications

PAINFUL CRISIS

Painful crisis: Limbs/Joints

Abdominal crisis and Girdle Syndrome

FEBRILE ILLNESS

ACUTE CHEST SYNDROME

ACUTE SEVERE ANEMIA

ACUTE SPLENIC SEQUESTRATION

COMPLICATIONS
1.Hepatobiliary
Cholelithiasis
Acute cholecystitis
Intrahepatic cholestasis
2. Neurological complications
Stroke
Seizure/convulsions

GENITOURINARY COMPLICATIONS
Priapism

Prevention
People who are known carriers of the
disease often undergo genetic
counselling before they have a child.
A test to see if an unborn child has the
disease takes either a blood sample from
the fetus or a sample of amniotic fluid.
Since taking a blood sample from a fetus
has greater risks, the latter test is usually
used.

ASSIGNGMENT 1
1.Describe the chronic complications of Sickle cell
disease.
2.Describe the reproductive health choices for patients
with Sickle cell disease.
3.Describe the specific diseases/conditions to be
screened for sickle cell patients.
4.Blood transfusion is a key therapeutic modality in
SCD. Describe three main types of blood transfusion
and rationales of transfusing sickle cell patients
Tags